Cooperation
UniXell relies on first-class scientific research institutes and hospitals, with good scientific research and clinical resources. At the end of 2022, the company and Ruijin Hospital launched a clinical research project on autologous stem cell therapy for Parkinson's disease, and has started to recruit healthy and Parkinson's disease blood donors for iPSCs construction.
